Zinc-binding to Leukocyte Cell Derived Chemotaxin 2 and Implications for its Associated Amyloidosis
Year: 2020
Type: dissertation
Abstract: Deposition of leukocyte cell-derived chemotaxin 2 (LECT2) as amyloid (ALECT2) leads to ALECT2 amyloidosis, an amyloid disease with no known cure. Recent findings indicate that ALECT2 amyloidosis is severely underdiagnosed. All sequenced ALECT2 amyloidosis patients have a single nucleotide polymorphism that changes an isoleucine (WT) to a valine (58V) at position 58. Currently, little is known of the mechanism by which the protein misfolds and aggregates. Herein, we demonstrate the first molecular characterization of the misfolding and aggregation of the mature LECT2 protein. Through various biophysical methods, we found that zinc-binding alters the secondary structure, increases the conformational stability, and reduces aggregation propensity of both WT and 58V-LECT2. No significant difference was found between the variants in their secondary structure, conformational stability, and zinc-binding affinity. However, zinc-free 58V-LECT2 was significantly more amyloidogenic than WT-LECT2. Therapies aimed at ALECT2 amyloidosis should exploit putative conformational differences between zinc-bound and zinc-free LECT2.
Source: TSpace (University of Toronto)
Author: Jethro Prinston
Institution: University of Toronto
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3153198943
